🧫
Activity-dependent regulation of PGC-1α in PV+ interneurons
active
experiment
Created: 2026-04-06T12:33:34
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-986efe0d-ed21-429e-91e3-1494a94b2111
🧫 Experiment Protocol
ExploratoryPPARGC1Amouse cortical neuronsproposed
This experiment investigated how neuronal activity triggers PGC-1α expression and function in PV+ interneurons. The researchers likely used activity manipulation protocols, such as pharmacological modulation of neural activity or optogenetic stimulation, to assess the relationship between neural activity and PGC-1α regulation. The experiment may have involved measuring PGC-1α expression levels, subcellular localization, and transcriptional activity in response to different activity states. This work was crucial for establishing that neuronal activity is the upstream signal that activates the PGC-1α-mediated molecular switch controlling PV+ interneuron maturation.
PRIMARY OUTCOME
Activity-dependent PGC-1α regulation
EXPECTED OUTCOMES
## Primary Outcomes
**PGC-1α Upregulation**: Activity-dependent increase in PGC-1α protein levels by ≥1.8-fold (p < 0.01, Student's t-test) following 7 days of 8 Hz optogenetic stimulation in PV+ neurons. Peak expression at DIV 16.
**Mitochondrial Adaptation**: Spare respiratory capacity increases by ≥40% in stimulated PV+ neurons vs. sham controls. Basal OCR elevated by ≥25%.
## Secondary Outcomes
**Subtype Specificity**: PGC-1α induction is ≥3× higher in PV+ interneurons vs. neighboring excitatory neurons (vGlut1+) in mixed cultures, confirming cell-type specificity of activity-dependent regulation.
**Functional Consequence**: PV+ interneurons showing enhanced PGC-1α expression display improved survival under metabolic stress conditions (glucose deprivation, 48 hours) with ≥30% reduction in TUNEL+ apoptotic cells.
SUCCESS CRITERIA
## Primary Success Criteria
**PGC-1α Induction**: Activity-dependent stimulation must produce ≥1.5-fold increase in PGC-1α protein expression (normalized to β-actin) in PV+ neurons, with statistical significance at p < 0.05 (one-way ANOVA with Bonferroni post-hoc test, n ≥ 4 biological replicates).
**Mitochondrial Function**: OCR spare capacity in stimulated PV+ neurons significantly exceeds unstimulated controls by ≥30% (p < 0.05).
## Secondary Success Criteria
**Cell-Type Specificity**: PV-specific PGC-1α induction confirmed by co-localization analysis (Pearson's coefficient ≥0.7 between PV and PGC-1α immunostaining signal in stimulated cultures).
**Dose-Response Relationship**: Incremental frequency stimulation (1 Hz, 4 Hz, 8 Hz, 15 Hz) produces graded PGC-1α response with EC₅₀ centered at 6-10 Hz range, confirming biological plausibility of activity coupling.
PROTOCOL
# Activity-Dependent Regulation of PGC-1α in PV+ Interneurons Protocol
## Phase 1: Primary Cortical Culture Preparation (Days 1-7)
**Cell Culture**: Dissect cortex from P14-P18 C57BL/6 mice (both sexes). Dissociate neurons via papain digestion (20 U/mL, 37°C, 30 min). Plate at density 80,000 cells/cm² on poly-D-lysine/laminin-coated 12-well plates. Culture in Neurobasal-A supplemented with B-27, 0.5 mM L-glutamine, and 1× penicillin/streptomycin. Maintain at 37°C, 5% CO₂.
**PV+ Interneuron Identification**: At DIV 14, verify PV+ interneuron population via immunocytochemistry: anti-parvalbumin (1:500, Abcam ab114246) and anti-GAD67 (1:200, Millipore MABN60). Count PV+ cells as percentage of DAPI+ nuclei (target: 15-25% PV+).
## Phase 2: Activity Manipulation Paradigm (Days 8-14)
**Optogenetic Stimulation**: Transduce neurons at DIV 7 with AAV9-CaMKIIa-ChrimsonR-tdTomato (Addgene #62722) or AAV9-CaMKIIa-eArchT3.0-eYFP (control). Apply 8 Hz light pulses (473 nm, 10 ms pulses, 5 s on/5 s off for 30 min/day) for 7 consecutive days.
**Chemogenetic Modulation**: For complementary experiments, apply DREADD hM3Dq (CNO, 5 μM) or hM4Di for 6 hours to modulate network activity. Measure spontaneous excitatory postsynaptic currents (sEPSCs) via patch clamp at DIV 14, 16, and 18.
## Phase 3: PGC-1α Expression Analysis (Days 15-21)
**Molecular Analysis**: Extract protein at 4 timepoints (baseline DIV7, post-stimulation DIV14/16/18). Probe with anti-PGC-1α (1:500, Abcam ab191695) and anti-β-actin (1:5000). Quantify via western blot with HRP-conjugated secondary antibodies and chemiluminescent detection (GE ECL). Normalize PGC-1α signal to β-actin loading control.
**Mitochondrial Function**: Measure mitochondrial mass via MitoTracker Deep Red FM (100 nM, 30 min, 37°C) and MitoSOX Red (5 μM, 10 min) for superoxide detection. Analyze via flow cytometry (Attune NxT) or high-content imaging (IN Cell 2200).
## Phase 4: Functional Validation (Days 22-28)
**Respirometry**: Measure oxygen consumption rate (OCR) via Seahorse XFe96 Analyzer. Sequence: oligomycin (1 μg/mL), FCCP (0.75 μM), rotenone/antimycin A (0.5 μM). Calculate basal respiration, max capacity, and spare respiratory capacity.
**ATF4 Target Analysis**: For mechanistic studies, include PGC-1α target gene panel: ATF4, ERR-α, NRF-1, NRF-2, and mitochondrial biogenesis markers (TFAM, COXI, ATP5A). Verify via qRT-PCR (ΔΔCt method).
LINKED HYPOTHESES
Source: PMID 40669459 ↗
🧫 Experiment Extras
PATHWAY
Activity-dependent transcriptional regulation
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.